Bath & Body Works' Q1 sales fall less than expected, adjusted EPS beats

Bath & Body Works, Inc.

Bath & Body Works, Inc.

BBWI

0.00


Overview

  • U.S. personal care retailer's Q1 net sales fell 3% but beat analyst expectations

  • Adjusted EPS for Q1 was $0.32, beating analyst expectations

  • CFO Eva Boratto to step down June 12; interim CFO appointed


Outlook

  • Bath & Body Works maintains 2026 net sales guidance of down 4.5% to down 2.5%

  • Company expects 2026 adj EPS of $2.40 to $2.65

  • Bath & Body Works forecasts Q2 net sales to decline 5% to 3%


Result Drivers

  • CORE CATEGORY INITIATIVES - Co said efforts to strengthen hero categories, modernize the brand, and expand reach are beginning to resonate with consumers, per CEO Daniel Heaf

  • SALES DECLINE - Q1 net sales fell 3%, with U.S. and Canada store sales down 4.3% and direct sales down 1.5%, partially offset by 9% growth in international and other sales


Company press release: ID:nGNX71Rbbh


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Beat

$1.38 bln

$1.36 bln (15 Analysts)

Q1 Adjusted EPS

Beat

$0.32

$0.29 (15 Analysts)

Q1 EPS

$0.90


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 13 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."

  • Wall Street's median 12-month price target for Bath & Body Works Inc is $25.00, about 41% above its May 26 closing price of $17.73

  • The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.